Symbols / ORPH
ORPH Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- ORPH.IR volume spike Open Orphan (EURONEXT) pre-market 25 Feb: liquidity rising - Meyka Wed, 25 Feb 2026 02
- 15,112 spike in ORPH.IR volume: Open Orphan Plc intraday 20 Feb 2026, watch - Meyka Fri, 20 Feb 2026 12
- 15,112 volume for ORPH.IR Open Orphan (EURONEXT) on 18 Feb 2026: check targets - Meyka Wed, 18 Feb 2026 10
- Volume spike close: ORPH.IR Open Orphan EURONEXT 11 Feb 2026 signals buyers - Meyka hu, 12 Feb 2026 08
- Why Dyne Therapeutics (DYN) Is Down 7.8% After Japan Grants Orphan Status To DM1 Drug - simplywall.st hu, 19 Feb 2026 13
- Assess Biotech Landscape Hazards Before Trading Orphazyme Stock - InvestorPlace ue, 22 Jun 2021 07
- Pre-Mkt spike ORPH.IR Open Orphan €0.14 EURONEXT 05/02/2026: watch liquidity - Meyka hu, 05 Feb 2026 00
- hVIVO PLC (AIM:HVO) Trading update - Share Talk Fri, 30 May 2025 07
- Tonix Pharma (TNXP) Stock Rallied 39% on a Patent Award. Is It a Buy? - AskTraders.com Wed, 01 Jun 2022 07
- hMPV Interview with Guy Boivin & hVIVO’s Chief Scientific Officer - Share Talk Wed, 19 Nov 2025 08
- Volume spike 30 Jan 2026: ORPH.IR Open Orphan Plc (EURONEXT) trading interest - Meyka Fri, 30 Jan 2026 08
- hVIVO PLC (AIM:HVO) Director/PDMR Shareholding - Share Talk Mon, 02 Jun 2025 07
- 15,112 pre-market spike: ORPH.IR Open Orphan Plc EURONEXT 15 Jan 2026, watch 0.14 - Meyka hu, 15 Jan 2026 08
- ORPH.IR Open Orphan Plc EURONEXT pre-market 22 Jan 2026: Volume surges to 15,112, monitor EUR 0.14 support - Meyka hu, 22 Jan 2026 08
- Open Orphan plc distribution in specie of Poolbeg Pharma plc shares – Q&A - Share Talk hu, 17 Mar 2022 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for ORPH
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|